Nutritional Status Implication at 6 Months in Parkinson’s Disease: Follow-Up Results
Objective: To analyze the relationship between nutritional status and weight in 3 groups of patients with Parkinson's disease (PD) who are receiving different pharmacological therapies…Behavioral health characteristics of pre-surgical Focused Ultrasound and Deep Brain Stimulation candidates
Objective: To characterize psychological traits in patients who pursue focused ultrasound (FUS) versus deep brain stimulation (DBS) for tremor management Background: Psychosocial characteristics can determine…Association Between Hypertension Timing and Clinical Variables in Parkinson’s Disease: A Retrospective Analysis
Objective: To investigate the correlation between hypertension and Parkinson's disease (PD) diagnoses' timing and clinical variables. Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder…Listening to the Insight: The Underdiagnosis of Depression in People Living with Parkinson’s Disease
Objective: To determine the prevalence of risk of undiagnosed depression among people living with Parkinson's disease (PwP) without a prior depression diagnosis. Background: Parkinson's disease…Creating a Multi-institutional, Interdisciplinary Functional Neurological Disorder (FND) Clinic in an Urban Setting
Objective: To describe the process to create an interdisciplinary FND clinic with independent practitioners in the New York City area. Background: Estimated 9,000 people in…Quantitative EEG Analysis for Comparing Drug-Induced Parkinsonism and Parkinson’s Disease
Objective: To know whether EEG could be a neural indicator that distinguish between Drug-induced parkinsonism (DIP) and Parkinson’s disease (PD). Background: DIP is the second…Characteristics of Parkinson’s disease and associated healthcare resource utilization trends in a US all-payer health administrative claims database
Objective: To describe sociodemographic characteristics and healthcare resource utilization (HRU) among Parkinson’s disease (PD) patients across US health insurance plans. Background: PD affects nearly 1…Parkinson’s disease in Brazil: prevalence and patient characteristics in a nationwide representative population-based cohort.
Objective: To assess the prevalence, sociodemographic, and clinical characteristics of Parkinson’s disease (PD) among Brazilian older adults in a large nationwide representative cohort. Background: The…Clinical profile of early-onset Parkinson’s disease
Objective: Describe motor and non-motor symptoms, complications and treatment in patients with early-onset Parkinson's disease (EOPD) Background: PD usually affecting people over age 60, clinically…Self-perception of Health and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.
Objective: To identify whether depressive symptomatology correlates with self-perception of health in patients with IPDWD. Background: Parkinson's disease is a neurodegenerative pathology characterized by motor…
- « Previous Page
- 1
- …
- 100
- 101
- 102
- 103
- 104
- …
- 181
- Next Page »
